Infectious diseases consultation reduces 30-day and 1-year all-cause mortality for multidrug-resistant organism infections.
Open accessThe DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Abstract
Background: Multidrug-resistant organism (MDRO) infections are associated with high mortality and readmission rates. Infectious diseases (ID) consultation improves clinical outcomes for drug-resistant Staphylococcus aureus bloodstream infections. Our goal was to determine the association between ID consultation and mortality following various MDRO infections. Methods: This study was conducted with a retrospective cohort (January 1, 2006–October 1, 2015) at an academic tertiary referral center. We identified patients with MDROs in a sterile site or bronchoalveolar lavage/bronchial wash culture. Mortality and readmissions within 1 year of index culture were identified, and the association of ID consultation with these outcomes was determined using Cox proportional hazards models with inverse weighting by the propensity score for ID consultation. Results: A total of 4214 patients with MDRO infections were identified. ID consultation was significantly associated with reductions in 30-day and 1-year mortality for resistant S. aureus (hazard ratio [HR], 0.48; 95% confidence interval [CI], 0.36–0.63; and HR, 0.73, 95% CI, 0.61–0.86) and Enterobacteriaceae (HR, 0.41; 95% CI, 0.27–0.64; and HR, 0.74; 95% CI, 0.59–0.94), and 30-day mortality for polymicrobial infections (HR, 0.51; 95% CI, 0.31–0.86) but not Acinetobacter or Pseudomonas. For resistant Enterococcus, ID consultation was marginally associated with decreased 30-day mortality (HR, 0.81; 95% CI, 0.62–1.06). ID consultation was associated with reduced 30-day readmission for resistant Enterobacteriaceae. Conclusions: ID consultation was associated with significant reductions in 30-day and 1-year mortality for resistant S. aureus and Enterobacteriaceae, and 30-day mortality for polymicrobial infections. There was no association between ID consultation and mortality for patients with resistant Pseudomonas, Acinetobacter, or Enterococcus, possibly due to small sample sizes. Our results suggest that ID consultation may be beneficial for patients with some MDRO infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Specialist consultation appears to be associated with improved patient outcomes for a variety of infectious syndromes [295–300].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [295]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Austin, P. C. (2009) · Statistics in Medicine · doi:10.1002/sim.3697 · Cited by 6,758 · cited 1×
“10 considered evidence of imbalance [20].”
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Performance standards for antimicrobial susceptibility testing
Weinstein, M. P., & Clinical (2019) · Clinical and Laboratory Standards Institute eBooks · Cited by 4,341
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599
Weiner, L. M., Webb, A. K., Limbago, B., Dudeck, M. A., Patel, J., Kallen, A. J., Edwards, J. R., & Sievert, D. M. (2016) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2016.174 · Cited by 1,313
Safdar, N., & Maki, D. G. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-11-200206040-00013 · Cited by 556
Micek, S. T., Lloyd, A. E., Ritchie, D. J., Reichley, R. M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1306-1311.2005 · Cited by 526
Self-citation
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Gardiner, B. J., Stewardson, A. J., Abbott, I. J., & Peleg, A. Y. (2019) · Australian Prescriber · doi:10.18773/austprescr.2019.002 · Cited by 167
Microbial Resistance to Antibiotics and Effective Antibiotherapy
Chiş, A. A., Rus, L. L., Morgovan, C., Arseniu, A. M., Frum, A., Vonica-Țincu, A. L., Gligor, F. G., Mureșan, M.-L., & Dobrea, C. M. (2022) · Biomedicines · doi:10.3390/biomedicines10051121 · Cited by 150
Role of the Pharmacist in Antimicrobial Stewardship
Parente, D. M., & Morton, J. B. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.05.009 · Cited by 134
Tiseo, G., Brigante, G., Giacobbe, D. R., Maraolo, A. E., Gona, F., Falcone, M., Giannella, M., Grossi, P., Pea, F., Rossolini, G. M., et al. (2022) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2022.106611 · Cited by 122
On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections
Morrisette, T., Miller, M. A., Montague, B. T., Barber, G. R., McQueen, R. B., & Kršák, M. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz162 · Cited by 93
Antimicrobial resistance in nephrology
Wang, T. Z., Kodiyanplakkal, R. P., & Calfee, D. P. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0150-7 · Cited by 90
Catheter removal and outcomes of multidrug-resistant central-line-associated bloodstream infection
Burnham, J. P., Rojek, R. P., & Kollef, M. H. (2018) · Medicine · doi:10.1097/md.0000000000012782 · Cited by 73
Self-citationManagement of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades?
Kamath, S., Altaq, H. H., & Abdo, T. (2023) · Microorganisms · doi:10.3390/microorganisms11092231 · Cited by 68
Easom, N. J. W., Moss, P., Barlow, G. D., Samson, A., Taynton, T., Adams, K., Ivan, M., Burns, P., Gajee, K., Eastick, K., et al. (2020) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12739 · Cited by 60
Meropenem antimicrobial stewardship program: clinical, economic, and antibiotic resistance impact
García-Rodríguez, J. F., García, B. B., Peña-Rodríguez, M. F., Álvarez, H., & Mariño-Callejo, A. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3408-2 · Cited by 62
Antimicrobial Treatment Duration in Sepsis and Serious Infections
Busch, L. M., & Kadri, S. S. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa247 · Cited by 63
Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children
Chiotos, K., Tamma, P. D., Flett, K. B., Karandikar, M. V., Nemati, K., Bilker, W. B., Zaoutis, T. E., & Han, J. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy222 · Cited by 53
Tan, B. H., Chakrabarti, A., Patel, A. K., Chua, M. M., Sun, P., Liu, Z., Rotjanapan, P., Li, R., Wahyuningsih, R., Chayakulkeeree, M., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.007 · Cited by 51
Telemedicine Infectious Diseases Consultations and Clinical Outcomes: A Systematic Review
Burnham, J. P., Fritz, S. A., Yaeger, L. H., & Colditz, G. A. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz517 · Cited by 45
“This is problematic because consultation with ID physicians significantly reduces mortality for numerous infections [3, 4].”
BackgroundSelf-citationShah, A., Petrak, R. M., Fliegelman, R. M., Shrestha, N. K. M., Allison, G. M., Zurlo, J. J., Parker, S., Poretz, D. M., McKinsey, D. S., Dougherty, M. J., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy674 · Cited by 48
Acinetobacter Pneumonia: Improving Outcomes With Early Identification and Appropriate Therapy
Guillamet, C. V., & Kollef, M. H. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy375 · Cited by 44
Self-citationLee, R. A., Vo, D. T., Zurko, J. C., Griffin, R. L., Rodriguez, J. M., & Camins, B. C. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa064 · Cited by 39
Inpatient addiction consultation and post-discharge 30-day acute care utilization
Weinstein, Z., Cheng, D. M., D'Amico, M. J., Forman, L. S., Regan, D., Yurkovic, A., Samet, J. H., & Walley, A. Y. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108081 · Cited by 38
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia
Cardozo, C., Cuervo, G., Salavert, M., Merino, P., Gioia, F., Fernández‐Ruiz, M., López-Cortés, L. E., Escolà‐Vergé, L., Montejo, M., Muñóz, P., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz491 · Cited by 29
Chesdachai, S., Kline, S., Helmin, D., & Rajasingham, R. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa010 · Cited by 29
Jorgensen, S. C. J., Trinh, T. D., Zasowski, E. J., Lagnf, A. M., Bhatia, S., Melvin, S. M., Simon, S. P., Rosenberg, J. R., Steed, M. E., Estrada, S. J., et al. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00288-4 · Cited by 26
Strich, J. R., Mishuk, A. U., Diao, G., Lawandi, A., Li, W., Demirkale, C. Y., Babiker, A., Mancera, A. G., Swihart, B., Walker, M. K., et al. (2024) · Annals of Internal Medicine · doi:10.7326/m23-2309 · Cited by 25
Yoon, H., Felsen, U. R., Wang, T., & Pirofski, L. (2019) · Medical Mycology · doi:10.1093/mmy/myz082 · Cited by 26
Zahn, M., Adalja, A. A., Auwaerter, P. G., Edelson, P. J., Hansen, G. R., Hynes, N. A., Jezek, A., MacArthur, R. D., Manabe, Y. C., McGoodwin, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy888 · Cited by 23
Livorsi, D. J., Nair, R., Lund, B. C., ALEXANDER, B. K., Beck, B. F., Goto, M., Ohl, M., Vaughan‐Sarrazin, M., Goetz, M. B., & Perencevich, E. N. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa388 · Cited by 22
Satlin, M. J., Weissman, S. J., Carpenter, P. A., Seo, S. K., & Shelburne, S. A. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2020.10.001 · Cited by 22
Infectious Diseases Consultation Associated With Reduced Mortality in Gram-Negative Bacteremia
Shulder, S., Tamma, P. D., Fiawoo, S., Dzintars, K., Escobar, D., Livorsi, D. J., Malani, A. N., Palacio, D., Spivak, E. S., Zimmerman, M., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad383 · Cited by 21
Impact of infectious diseases consultation on the outcome of patients with bacteraemia
Jiménez-Aguilar, P., López-Cortés, L. E., & Rodríguez‐Baño, J. (2019) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936119893576 · Cited by 20
Chiong, F. J. K., Wasef, M. S., Liew, K. C., Cowan, R. U., Tsai, D., Lee, Y. P., Croft, L., Harris, O. M., Gwini, S. M., & Athan, E. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06372-5 · Cited by 19
Prevention and Treatment of Multidrug-Resistant Organisms in End-Stage Renal Disease
Midturi, J. K., & Ranganath, S. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2018.09.003 · Cited by 18
Klatt, M. E., Schulz, L. T., Fleischman, D., Fox, B. C., Burke, S., Grinder, D., Rose, W. E., Lepak, A. J., & Andes, D. R. (2021) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxab263 · Cited by 16
Kishida, N., & Nishiura, H. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.051 · Cited by 16
Bork, J. T., Claeys, K. C., Heil, E. L., Banoub, M. G., Leekha, S., Sorkin, J. D., & Kleinberg, M. E. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00307-20 · Cited by 15
Cognitive biases and knowledge deficits leading to delayed recognition of cryptococcal meningitis
Deming, M. E., Mark, A., Nyemba, V., Heil, E. L., Palmeiro, R., & Schmalzle, S. A. (2019) · IDCases · doi:10.1016/j.idcr.2019.e00588 · Cited by 15
Peiffer‐Smadja, N., Ardellier, F.-D., Thill, P., Beaumont, A., Catho, G., Osei, L., Dubée, V., Bleibtreu, A., Lemaignen, A., & Thy, M. (2020) · BMC Medical Education · doi:10.1186/s12909-020-02317-9 · Cited by 14
Calderón‐Parra, J., Jiménez, J. H., Ramos, A., Múñez, E., Callejas‐Díaz, A., de Santiago, A. D., Sánchez‐Romero, I., Dosil, M. L., & Fernández‐Cruz, A. (2021) · Mycoses · doi:10.1111/myc.13275 · Cited by 13
[Consensus document for sepsis code implementation and development in the Community of Madrid].
Herrejon, E. P., del Castillo, J. M. G., Rueda, F. R., Candel, F. J., Artola, B. S., Teleki, A. V. W., Vidal, F. G., Iglesias, P. R., Redondo, G. B., Rodríguez-Serrano, D. A., et al. (2019) · PubMed Central · Cited by 19
Guo, Q., Wei, Y., Zhao, Q., Zhang, W., Lv, P., Zhou, Z., & Wang, S. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s515207 · Cited by 11
Jover-Sáenz, A., Ramírez-Hidalgo, M. F., Vidal, M. V., García-González, M., Marrón, S. C., Escartín, A., Sacrest, M. F., Perelló, D. C., & Barcenilla-Gaite, F. (2020) · Infection Prevention in Practice · doi:10.1016/j.infpip.2020.100048 · Cited by 11
Giannella, M., Malosso, P., Scudeller, L., Bussini, L., Rebuffi, C., Gatti, M., Bartoletti, M., Ianniruberto, S., Pancaldi, L., Pascale, R., et al. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106320 · Cited by 11
Clinical outcomes and epidemiological characteristics of bacteremia in the older Japanese population
Nakamura, K., Hayakawa, K., Tsuzuki, S., Ide, S., Nomoto, H., Nakamoto, T., Yamada, G., Yamamoto, K., & Ohmagari, N. (2023) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2023.06.015 · Cited by 10
Papadimitriou‐Olivgeris, M., Senn, L., Jacot, D., & Guery, B. P. (2024) · Infection · doi:10.1007/s15010-024-02326-6 · Cited by 10
Burnham, J. P., Fritz, S. A., Yaeger, L., & Colditz, G. A. (2019) · Systematic Reviews · doi:10.1186/s13643-019-1056-y · Cited by 10
Self-citationWeis, S., Hagel, S., Palm, J., Scherag, A., Kolanos, S., Bahrs, C., Löffler, B., Schmitz, R. P. H., Rißner, F., Brunkhorst, F. M., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.18515 · Cited by 10
Ramanathan, S., Albarillo, F. S., Fitzpatrick, M. A., Suda, K. J., Poggensee, L., Vivo, A., Evans, M. E., Jones, M., Safdar, N., Pfeiffer, C., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac456 · Cited by 10
Kaur, H., Krishnamoorthi, S., Dhaliwal, N., Biswal, M., Singh, S., Muthu, V., Rudramurthy, S. M., Agarwal, R., Ghoshal, S., Singh, S., et al. (2022) · Mycoses · doi:10.1111/myc.13514 · Cited by 9
Cabanilla, M. G., Bernauer, M. L., Briski, M. J., Atallah, L. M., Koury, J., Thompson, C. M., Rodriguez, C. N., Jakeman, B., & Byrd, T. F. (2024) · Journal of Pharmacy Technology · doi:10.1177/87551225241227796 · Cited by 8
Tractable targets for meropenem-sparing antimicrobial stewardship interventions
Russell, C. D., Laurenson, I. F., Evans, M. H., & Mackintosh, C. L. (2019) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlz042 · Cited by 8
Park, S. C., Wailan, A. M., Barry, K. E., Vegesana, K. B., Carroll, J., Mathers, A. J., Miller, W. R., & Munita, J. M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00029-19 · Cited by 8
Yeung, C. M., Suhardi, V. J., Varady, N. H., Eizember, S. C., Lichstein, P. M., Maguire, J. H., Chen, A. F., & Estok, D. M. (2020) · The Journal of Arthroplasty · doi:10.1016/j.arth.2020.10.002 · Cited by 7
A Needs Assessment for Infectious Diseases Consultation in Community Hospitals
Hollingshead, C. M., Khazan, A. E., Franco, J. H., Ciricillo, J. A., Haddad, M. N., Berry, J. T., & Kammeyer, J. A. (2023) · Infectious Diseases and Therapy · doi:10.1007/s40121-023-00810-4 · Cited by 7
Burnham, J. P., Kwon, J. H., Olsen, M. A. A., Babcock, H. M., & Kollef, M. H. (2018) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2018.142 · Cited by 7
Self-citationBurnham, J. P. (2025) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed10040105 · Cited by 6
Self-citationItoh, N., Akazawa, N., Kawabata, T., Yamaguchi, M., Kodama, E. N., & Ohmagari, N. (2024) · Scientific Reports · doi:10.1038/s41598-024-53543-w · Cited by 6
Makina, A., Poulakou, G., Sympardi, S., Souli, M., Liakopoulou, E., Matthaiou, D. K., Karaiskou, A., Arvaniti, A., Charalabaki, N., Antoniadou, A., et al. (2019) · Infectious Diseases and Clinical Microbiology · doi:10.5152/idcm.2019.19003 · Cited by 6
Endophytes: The Unmapped Repository for Natural Products
Sarethy, I. P., Srivastava, N., & Pan, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-7154-7_2 · Cited by 6
Santibañez, M., Bunnell, K. L., Harrington, A., Bleasdale, S. C., & Wenzler, E. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz400 · Cited by 6
Du, Q., Xi, X., Dong, J., Zhang, T., Li, D., Dong, Y., Li, W., Huang, G., Zhu, J., Ran, H., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1128219 · Cited by 5
Telemedicine Offers Solutions for the Rural Disparities in Infectious Disease (ID) Care Delivery
Perez, C. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf052 · Cited by 5
Thind, S. K., Shibib, D. R., & Gentry, C. A. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab426 · Cited by 5
Bavaro, D. F., Gennaro, N. D., Belati, A., Diella, L., Papagni, R., Frallonardo, L., Camporeale, M., Guido, G., Pellegrino, C., Marrone, M., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12040712 · Cited by 5
Morrisette, T., Canada, R. B., Padgett, D., & Hudson, J. Q. (2018) · Hospital Pharmacy · doi:10.1177/0018578718817944 · Cited by 4
Burnham, J. P., Fritz, S. A., & Colditz, G. A. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac523 · Cited by 4
Self-citationMerli, M., D’Amico, F., Travi, G., & Puoti, M. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3020030 · Cited by 4
Palm, J., Alaid, S., Ammon, D., Brandes, J., Dürschmid, A., Fischer, C., Fortmann, J., Friebel, K., Geihs, S., Hartig, A.-K., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01569-3 · Cited by 4
Guillamet, C. V., Burnham, J. P., Pérez, M., Kollef, M. H., Manthous, C. A., & Jeffe, D. B. (2022) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2021.389 · Cited by 4
Self-citationComparison of Periodic In-person ID Care to Daily Tele-ID Care at a Community Hospital
Nanjappa, S., Volpe, P. A., Gupta, N., Li, S. K., Perez, C., Gass, K., Mellors, J. W., & Abdel-Massih, R. C. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf371 · Cited by 3
Nigo, M., Hasbun, R., & Vigil, K. J. (2018) · OBM Transplantation · doi:10.21926/obm.transplant.1804023 · Cited by 3
Carbapenem-resistant Enterobacteriaceae Infections: A Review of Epidemiology and Treatment Options
Harting, J. (2019) · The University of Louisville Journal of Respiratory Infections · doi:10.18297/jri/vol3/iss1/4 · Cited by 3
Assimakopoulos, S. F., Lazaris, V., Papadimitriou‐Olivgeris, M., Lagadinou, M., Verigou, E., Tzouvara, E., Kolonitsiou, F., Christofidou, M., Symeonidis, A. S., & Marangos, M. N. (2020) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2020.1741676 · Cited by 3
Factors associated with infectious diseases fellowship academic success
Khodadadi, R. B., Yetmar, Z. A., Domonoske, C. L., & Razonable, R. R. (2024) · Medical Education Online · doi:10.1080/10872981.2024.2352953 · Cited by 2
Farthing, T. S., Jolley, A., Nickel, K. B., Hill, C., Stwalley, D. L., Reske, K. A., Kwon, J. H., Olsen, M. A. A., Burnham, J. P., Dubberke, E. R., et al. (2023) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2023.83 · Cited by 2
Self-citationGreen, R. S., Daneff, M., Opra, I., Hurley, S. T., Gillis, B., Sturge, S., Cashen, D., & Green, D. (2026) · Healthcare Management Forum · doi:10.1177/08404704261417932 · Cited by 1
Hornuß, D., Mathé, P., Giesen, R., Escolà‐Vergé, L., Isler, B., Bartoletti, M., Lamy, B., Wagner, D., Kern, W. V., & Rieg, S. (2026) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2026.03.006 · Cited by 1
Trachuk, P., Hemmige, V. S., Eisenberg, R. E., Cowman, K., Chen, V., Weston, G. D., Gendlina, I., Ferguson, N., Dicpinigaitis, P. V., Berger, J., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab182 · Cited by 1
Bingen, J., Krueger, R., Lakatos, A. E. B., Raaum, J., & Kron, M. (2022) · AL-Kindy College Medical Journal · doi:10.47723/kcmj.v18i2.855 · Cited by 1
Takamatsu, A., & Honda, H. (2023) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2023.121 · Cited by 1
An evaluation of 1 year of advice calls to a tropical and infectious disease referral Centre
Wingfield, T., Beadsworth, M., Beeching, N. J., Gould, S., Mair, L., & Nsutebu, E. F. (2020) · Clinical Medicine · doi:10.7861/clinmed.2019-0201 · Cited by 1
Represa, M., Lima, O., Ávila, M., Rubiñán, P., Torres, C., Sansón-León, S., Adan, J. C. L., Álvarez-Fernández, M., Rubianes, M., Legarra, J. J., et al. (2025) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2025.06.005
Al-Anzi, M. A., Alenazi, S. B., Azeb, K. A., Aljabbab, A. A., Aloufi, B. A., Fal, S. A. M., Alziyaidi Hassan Mohammed, Z., Alyami, A., Alqahtani Mesfer Abdullah, A., AlAqil, A. Y. A., et al. (2024) · International Journal of Computational and Experimental Science and Engineering · doi:10.22399/ijcesen.4093
Leis, B. T., Mahee, C., Connors, W. J. A., Davierwala, P. M., Brothers, T. D., Morton, L. “., Lennox, R., Adams, C. A., Fairgrieve, C., Connelly, K. A., et al. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.11.009
FHIRing up clinical trials: a framework for interoperability-based data analysis
Palm, J. (2025) · Common Library Network (Der Gemeinsame Bibliotheksverbund) · doi:10.22032/dbt.67512
Physicians’ perspectives on antimicrobial resistance and rational antibiotic prescribing
Villaseñor-Echavarri, R., & Velez-Pintado, M. (2026) · American Journal of Infection Control · doi:10.1016/j.ajic.2026.02.236
Haapia, T., Vuopio, J., Oksi, R., Vahlberg, T. J., Silvola, J., & Kanerva, M. J. (2026) · Infection and Drug Resistance · doi:10.2147/idr.s556192
Crews-Stowe, C., & Sklar, E. M. (2026) · American Journal of Infection Control · doi:10.1016/j.ajic.2026.04.005
Fiori, C., Piana, A., Manfredi, M., & Amparore, D. (2026) · Springer eBooks · doi:10.1007/978-3-031-52619-0_7
Marx, K., Kellner, N., Herrmann, N., & Lübbert, C. (2026) · Infection · doi:10.1007/s15010-026-02902-y
Moyo, M., & Njiba, R. K. (2026) · Water Science & Technology · doi:10.2166/wst.2026.348
Infectious diseases specialists as clinical auditors: a lock-and-key fit
Ishak, A., Mazonakis, N., Alexakis, K., Tsioutis, C., Agouridis, A. P., & Spernovasilis, N. A. (2026) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2026.10860
Metadata
- Authors
- Burnham, J. P., Olsen, M. A., Stwalley, D., Kwon, J. H., Babcock, H. M., & Kollef, M. H.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Burnham, Jason P
- ORCID
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-03-01
- Volume
- 5
- Issue
- 3
- Pages
- ofy026-ofy026
- ISSN
- 2328-8957 (ISSN-L)
- PMC
- PMC5852998
- OpenAlex
- W2793814333
- Semantic Scholar
- 4589fb9304d7f66245829f29be9c42d9c1c3eebc
- Cited by
- 90
- References
- 30
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 6 · 2023: 9 · 2022: 8 · 2021: 9 · 2020: 15 · 2019: 17 · 2018: 10
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Open Forum Infectious Diseases (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Funders
- Washington University Institute of Clinical and Translational Sciences (UL1TR000448, KL2TR000450)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- multidrug-resistant organisms, infectious disease consultation, mortality, hospital readmission, co-infection, Acinetobacter, Pseudomonas, intensive care unit, antimicrobial resistance, 30-day mortality, one-year mortality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.